Adicet Bio (ACET) Other Operating Expenses (2023)
Adicet Bio (ACET) posted Other Operating Expenses of $19.5 million for Q3 2023.
Analysis
Adicet Bio (ACET) Other Operating Expenses (2023) Analysis & Trends
Adicet Bio has reported Other Operating Expenses for 1 years, with the latest figure at $19.5 million in Q3 2023.
- On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $19.5 million in Q3 2023; TTM through Jun 2024 was $19.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $466000.0, up 110.86% from the prior year.
- Other Operating Expenses was $19.5 million for Q3 2023 at Adicet Bio.
- The five-year high for Other Operating Expenses was $19.5 million in Q3 2023, with the low at $19.5 million in Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.36 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.03 Bn | 5.03 Bn | - |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.35 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn |
| 5 | uniQure | 2.98 Bn | 2.98 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.52 Bn | 2.52 Bn | - |
| 7 | Precigen | 2.38 Bn | 2.38 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.14 Bn | 1.35 Bn | 251.87 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn |
| 10 | Adicet Bio | 100.58 Mn | -17.61 Mn | - |